476.5000 1.55 (0.33%)
NSE Sep 19, 2025 15:31 PM
Volume: 84,736
 

476.50
0.33%
ICICI Securities Limited
Akums Drugs and Pharmaceuticals (Akums)’s Q1FY26 revenue was muted due to slowdown across verticals; however, better product mix aided gross margin expansion (+170bps YoY).
Akums Drugs & Pharmaceuticals Ltd. has lost -43.35% in the last 1 Year
More from Akums Drugs & Pharmaceuticals Ltd.
Recommended